Liquidia (LQDA) Gains from Sales and Divestitures (2020 - 2026)

Liquidia (LQDA) recorded quarterly Gains from Sales and Divestitures of $824292.0 in Q1 2026, down 41.2% quarter-over-quarter from $1.4 million in Q4 2025, and up 99.08% on a YoY basis from $414053.0 in Q1 2025.

Liquidia (LQDA) Gains from Sales and Divestitures (2020 - 2026) Analysis & Trends

Liquidia's Gains from Sales and Divestitures history runs 7 years deep, the most recent figure standing at $824292.0 for Q1 2026.

  • In Q1 2026, Gains from Sales and Divestitures rose 99.08% year-over-year to $824292.0; the TTM figure through Mar 2026 stood at $824292.0 (up 99.08% YoY), while the FY2025 annual figure was $1.4 million, up 93.36% from the prior year.
  • Gains from Sales and Divestitures was $824292.0 for Q1 2026 at Liquidia, down from $1.4 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $1.4 million in Q4 2025 to a low of $54181.0 in Q4 2022.
  • Historically, Gains from Sales and Divestitures has averaged $506531.2 across 5 years, with a median of $383133.0 in 2024.
  • Biggest YoY gain for Gains from Sales and Divestitures was 3241.11% in 2022; the steepest drop was 79.95% in 2022.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $54181.0 in 2022, then soared by 272.6% to $201880.0 in 2023, then surged by 259.14% to $725038.0 in 2024, then jumped by 93.36% to $1.4 million in 2025, then slumped by 41.2% to $824292.0 in 2026.
  • The last three Gains from Sales and Divestitures figures came in at $824292.0 (Q1 2026), $1.4 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 824,292.00
Mar 31, 2026 824,292.00
Dec 31, 2025 1.40 Mn
Dec 31, 2025 1.40 Mn
Sep 30, 2025 1.18 Mn
Sep 30, 2025 1.18 Mn
Jun 30, 2025 942,683.00
Jun 30, 2025 942,683.00
Mar 31, 2025 414,053.00
Mar 31, 2025 414,053.00
Dec 31, 2024 725,038.00
Dec 31, 2024 725,038.00
Sep 30, 2024 615,827.00
Sep 30, 2024 615,827.00
Jun 30, 2024 499,580.00
Jun 30, 2024 499,580.00
Mar 31, 2024 383,133.00
Mar 31, 2024 383,133.00
Dec 31, 2023 201,880.00
Dec 31, 2023 201,880.00